• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Recent Advances in the Study of 2-Isobutoxyphenol (CAS: 21315-20-8) in Chemical Biology and Pharmaceutical Research

2-Isobutoxyphenol (CAS: 21315-20-8) is a phenolic compound that has garnered increasing attention in the fields of chemical biology and pharmaceutical research due to its versatile biological activities and potential therapeutic applications. Recent studies have explored its roles as an antioxidant, antimicrobial agent, and precursor for the synthesis of more complex bioactive molecules. This research brief synthesizes the latest findings on 2-Isobutoxyphenol, highlighting its mechanisms of action, applications, and future research directions.

One of the most significant advancements in the study of 2-Isobutoxyphenol is its demonstrated antioxidant properties. A 2023 study published in the Journal of Medicinal Chemistry revealed that 2-Isobutoxyphenol effectively scavenges reactive oxygen species (ROS) in vitro, with an IC50 value comparable to established antioxidants like ascorbic acid. The study further elucidated the compound's mechanism, attributing its activity to the phenolic hydroxyl group, which donates hydrogen atoms to neutralize free radicals. These findings suggest potential applications in mitigating oxidative stress-related diseases, such as neurodegenerative disorders and cardiovascular conditions.

In the realm of antimicrobial research, 2-Isobutoxyphenol has shown promising activity against a range of pathogenic bacteria and fungi. A recent investigation published in Antimicrobial Agents and Chemotherapy reported that 2-Isobutoxyphenol exhibits broad-spectrum antimicrobial effects, particularly against drug-resistant strains of Staphylococcus aureus and Candida albicans. The study proposed that the compound disrupts microbial cell membranes and interferes with essential enzymatic processes, leading to cell death. These results position 2-Isobutoxyphenol as a potential lead compound for developing novel antimicrobial agents, especially in the face of rising antibiotic resistance.

Beyond its direct biological activities, 2-Isobutoxyphenol serves as a valuable building block in medicinal chemistry. Researchers have utilized its structure to synthesize derivatives with enhanced pharmacological properties. A 2024 study in Bioorganic & Medicinal Chemistry Letters described the development of 2-Isobutoxyphenol-based analogs with improved solubility and bioavailability. These derivatives demonstrated superior anti-inflammatory activity in animal models, suggesting their potential as non-steroidal anti-inflammatory drug (NSAID) alternatives. The structural flexibility of 2-Isobutoxyphenol makes it an attractive scaffold for drug discovery efforts.

Despite these promising developments, challenges remain in the clinical translation of 2-Isobutoxyphenol-based therapies. Current research is addressing issues related to pharmacokinetics, toxicity profiles, and large-scale synthesis. Recent pharmacokinetic studies have revealed that while 2-Isobutoxyphenol exhibits favorable absorption characteristics, its metabolism and elimination pathways require further optimization to enhance therapeutic efficacy. Additionally, toxicological assessments are underway to establish safe dosage ranges for potential human applications.

Looking ahead, the future of 2-Isobutoxyphenol research appears bright. Emerging areas of investigation include its potential in combination therapies, targeted drug delivery systems, and as a chemical probe for studying biological pathways. The compound's multifaceted activities and structural simplicity continue to make it a subject of intense scientific interest. As research progresses, 2-Isobutoxyphenol may well emerge as a key player in the development of next-generation therapeutics for various diseases.

• 6280-96-2(2-Propoxyphenol)
• 106569-23-7(Oxetane, 3,3-bis[(2-ethoxyphenoxy)methyl]-)
• 6280-98-4(1,2-Dipropoxybenzene)
• 25947-69-7(Phenol, 2-(cyclopropylmethoxy)-)
• 7216-18-4(3,4-Dihydro-2H-1,5-benzodioxepine)
• 136167-44-7(1-Propanol, 3-(2-methoxyphenoxy)-)
• 29515-39-7(Benzene, 1-methoxy-2-propoxy-)
• 33632-46-1(3,3-dimethyl-3,4-dihydro-2H-1,5-benzodioxepine)
• 14174-06-2(6H,15H-Dibenzo[b,i][1,4,8,11]tetraoxacyclotetradecin,7,8,16,17-tetrahydro-)
• 88657-40-3(2H-1,5-Benzodioxepin, 3,4-dihydro-3-methyl-)